Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Sisram Medical to Report H1 2023 Financial Results on August 23 and Hold a Conference Call on August 24 2023-08-20 10:14
TradeUP Acquisition Corp. Announces Extension of the Deadline for an Initial Business Combination 2023-08-19 04:30
Boryung Partners with AIAA to Host 'Humans In Space Symposium' at 2023 ASCEND 2023-08-19 01:00
3Z and biotx.ai Forge Partnership to Advance ADHD Drug Development Using AI Modelling 2023-08-18 22:45
World Leading Rehabilitation Expert Prof. Dr. Christopher Gutenbrunner Visits Siyi Intelligence 2023-08-18 21:00
VIGILL Triumphs as "Excellence in Women's Intimate Hygiene Products Brand" at The LICTA 2022 Awards 2023-08-18 19:15
Inmagene's anti-OX40 mAb demonstrated an extended half-life and a favorable safety profile in a Phase I study 2023-08-18 19:00
Nature-inspired pressure sensing technology aims to transform healthcare and surgical robots 2023-08-18 17:54
United Imaging Healthcare delivers its 2023 Half-Year report, with revenue growth of 26.35% in the first half of 2023 2023-08-18 17:29
JinMed (NASDAQ: ZJYL) Rings the Nasdaq Stock Market Closing Bell on August 17 2023-08-18 11:36
QiLu Pharmaceutical's Iruplinalkib Phase III INSPIRE Study Researched Primary Endpoint and was Selected for 2023 WCLC Oral Presentation 2023-08-18 09:50
Thrombotic AEs of Hemlibra (emicizumab) were 2.8 times more frequent than those of FVIII replacements. 2023-08-18 08:58
Everest Medicines' Partner Calliditas Therapeutics Announces Full Results From NefIgArd Phase 3 Trial published in The Lancet 2023-08-18 08:41
The Global Medical Robotics Conference 2023: A Deep Dive into China's Booming Surgical Robotics Landscape 2023-08-18 02:08
BoomerangFX expands into Australian Market Driven by Growing Demand for Aesthetic Medicine Services in Asia Pacific 2023-08-18 00:01
Neurophth Announces First Patient Dosed in Phase I/II Clinical Trial of Second Gene Therapy 2023-08-17 21:00
Minghui Pharmaceutical Inc. Announces First Patient Enrollment in the Phase 3 Clinical Study of MH004 Cream for Treatment of Mild to Moderate Atopic Dermatitis 2023-08-17 19:00
I-Mab Provides Mid-Year 2023 Financial Results, Business and Corporate Updates 2023-08-17 18:00
2023WCLC Oral Presentation | Molecular Analysis Validates the Effectiveness of Tumor Tissue-Based and Plasma ctDNA Testing in Identifying NSCLC Patients with EGFR Exon20ins Eligible for Treatment with Sunvozertinib 2023-08-17 17:10
Capco's Singapore 2023 insurance survey highlights opportunities for insurers to use innovative data and personalization strategies to meet evolving customer needs 2023-08-17 10:00
1 113 114 115 116 117 1502